Corrigendum to "Multidrug resistance protein 1 is not associated to detergent-resistant membranes" [Biochem. Biophys. Res. Commun. 355 (2007) 1025-1030] (DOI:10.1016/j.bbrc.2007.02.075);Multidrug resistance protein 1 is not associated to detergent-resistant membranes

Biochemical and Biophysical Research Communications

Volumn 355, Issue 4, 2007, Pages 1025-1030

  Cerf, Emilie ^a   Gasper, Régis ^a   Rychnovsky, Scott ^b   Chang, Xiu bao ^c   Buyse, Frédéric ^a   Ruysschaert, Jean Marie ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

ATP binding cassette (ABC); ATPase activity; Cholesterol; Detergent resistant membrane; MRP1; Transport activity

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CHOLESTEROL; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; SPHINGOLIPID; TRITON X 100;

ARTICLE; CELL MEMBRANE; CELL MEMBRANE RESISTANCE; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; DRUG TRANSPORT; EMBRYO; ENZYME ACTIVITY; EXTRACTION; HUMAN; HUMAN CELL; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; UPREGULATION;

EID: 33847664622     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.016     Document Type: Erratum

References (37)

1. Hipfner D.R., Deeley R.G., and Cole S.P.C. Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta 1461 (1999) 359-376
2. Juliano R.L., and Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455 (1976) 152-162
3. Lavie Y., Fiucci G., and Liscovitch M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273 49 (1998) 32380-32383
4. Barakat S., Gayet L., Dayan G., Labialle S., Lazar A., Oleinikov V., Coleman A.W., and Baggetto L.G. Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated P-gp ATPase activities: evidence from atomic force microscopy and biochemical analysis. Biochem. J. 388 (2005) 563-571
5. Troost J., Lindenmaier H., Haefeli W.E., and Weiss J. Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells. Mol. Pharmacol. 66 5 (2004) 1332-1339
6. Gayet L., Dayan G., Barakat S., Labialle S., Michaud M., Cogne S., Mazane A., Coleman A.W., Rigal D., and Baggetto L.G. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells. Biochemistry 44 11 (2005) 4499-4509
7. Modok S., Heyward C., and Callaghan R. P-glycoprotein retains function when reconstituted into a sphingolipid- and cholesterol-rich environment. J. Lipid Res. 45 10 (2004) 1910-1918
8. Rothnie A., Theron D., Soceneantu L., Martin C., Traikia M., Berridge G., Higgins C.F., Devaux P.F., and Callaghan R. The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence. Eur. Biophys. J. 30 6 (2001) 430-442
9. Manciu L., Chang X.-B., Buyse F., Hou Y.-X., Gustot A., Riordan J.R., and Ruysschaert J.M. Intermediate structural states involved in MRP1-mediated drug transport. Role of glutathione. J. Biol. Chem. 278 (2003) 3347-3356
10. 35S]glutathione. J. Biol. Chem. 277 (2002) 35225-35231
11. Bickel P.E., Scherer P.E., Schnitzer J.E., Oh P., Lisanti M.P., and Lodish H.F. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J. Biol. Chem. 272 21 (1997) 13793-13802
12. Örtegren U., Karlsson M., Blazic N., Blomqvist M., Nystrom F.H., Gustavsson J., Fredman P., and Strålfors P. Lipids and glycosphingolipids in caveolae and surrounding plasma membrane of primary rat adipocytes. Eur. J. Biochem. 271 (2004) 2028-2036
13. Manciu L., Chang X.-B., Riordan J.R., and Ruysschaert J.M. Multidrug resistance protein MRP1 reconstituted into lipid vesicles: secondary structure and nucleotide-induced tertiary structure changes. Biochemistry 39 (2000) 13026-13033
14. Manciu L., Chang X., Riordan J.R., Buyse F., and Ruysschaert J.M. Nucleotide-induced conformational changes in the human multidrug resistance protein MRP1 are related to the capacity of chemotherapeutic drugs to accumulate or not in resistant cells. FEBS Lett. 493 1 (2001) 31-35
15. Mao Q., Leslie E.M., Deeley R.G., and Cole S.P. ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells. Biochim. Biophys. Acta 1461 (1999) 69-82
16. Hinrichs J.W., Klappe K., Hummel I., and Kok J.W. ATP-binding cassette transporters are enriched in non-caveolar detergent-insoluble glycosphingolipid-enriched membrane domains (DIGs) in human multidrug-resistant cancer cells. J. Biol. Chem. 279 7 (2004) 5734-5738
17. Radeva G., and Sharom F.J. Isolation and characterization of lipid rafts with different properties from RBL-2H3 (rat basophilic leukaemia) cells. Biochem. J. 380 (2004) 219-230
18. Radeva G., Perabo J., and Sharom F.J. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains. FEBS J. 272 19 (2005) 4924-4937
19. Orlowski S., Martin S., and Escargueil A. P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?). Cell. Mol. Life Sci. 63 9 (2006) 1038-1059
20. Luker G.D., Pica C.M., Sampath Kumar A., Covey D.F., and Piwnica-Worms D. Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains. Biochemistry 39 (2000) 7651-7661
21. Garrigos M., Belehradek Jr. J., Mir L.M., and Orlowski S. Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles. Biochem. Biophys. Res. Commun. 196 3 (1993) 1034-1041
22. Troost J., Albermann N., Emil Haefeli W., and Weiss J. Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 316 3 (2004) 705-711
23. Dijkhuis A.J., Klappe K., Kamps W., Sietsma H., and Kok J.W. Gangliosides do not affect ABC transporter function in human neuroblastoma cells. J. Lipid Res. 47 6 (2006) 1187-1195
24. van Laethem F., Liang X., Andris F., Urbain J., Vandenbranden M., Ruysschaert J.M., Resh M.D., Stulnig T.M., and Leo O. Glucocorticoids alter the lipid and protein composition of membrane rafts of a murine T cell hybridoma. J. Immunol. 170 6 (2003) 2932-2939
25. Gidwani A., Holowka D., and Baird B. Fluorescence anisotropy measurements of lipid order in plasma membranes and lipid rafts from RBL-2H3 mast cells. Biochemistry 40 41 (2001) 12422-12429
26. Westover E.J., and Covey D.F. The enantiomer of cholesterol. J. Membr. Biol. 202 (2004) 61-72
27. Kowalski M.P., and Pier G.B. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J. Immunol. 172 1 (2004) 418-425
28. Epand R.M. Cholesterol and the interaction of proteins with membrane domains. Prog. Lipid Res. 45 4 (2006) 279-294
29. Li H., and Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139 (1998) 4991-4997
30. Kuwabara P.E., and Labouesse M. The sterol-sensing domain: multiple families, a unique role. Trends Genet. 18 (2002) 193-201
31. Arima H., Yunomae K., Morikawa T., Hirayama F., and Uekama K. Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-beta-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers. Pharm. Res. 21 (2004) 625-634
32. Tietz P., Jefferson J., Pagano R., and Larusso N.F. Membrane microdomains in hepatocytes: potential target areas for proteins involved in canalicular bile secretion. J. Lipid Res. 46 (2005) 1426-1432
33. Evers R., Zaman G.J.R., van Deemter L., Jansen H., Calafat J., Oomen L.C.J.M., Oude Elferink R.P.J., Borst P., and Schinkel A.H. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J. Clin. Invest. 97 (1996) 1211-1218
34. Gottesman M.M., and Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62 (1993) 385-427
35. Verkade P., and Simons K. Robert Feulgen Lecture 1997. Lipid microdomains and membrane trafficking in mammalian cells. Histochem. Cell Biol. 108 3 (1997) 211-220
36. Shapiro A.B., and Ling V. ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J. Biol. Chem. 269 (1994) 3745-3754
37. Hasegawa S., Abe T., Naito S., Kotoh S., Kumazawa J., Hipfner D.R., Deeley R.G., Cole S.P.C., and Kuwano M. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Br. J. Cancer 71 (1995) 907-913